• 2023
  Safi R, Sánchez-Álvarez M, Bosch M, Demangel C, Parton RG, Pol A, , Defensive-lipid droplets: Cellular organelles designed for antimicrobial immunity., Immunol Rev 2023 Mar; (): .
• 2023
  Laval T, Demangel C, , Click-chemistry-based protocol to quantitatively assess fatty acid uptake by Mycobacterium tuberculosis in axenic culture and inside mouse macrophages., STAR Protoc 2023 Jan; 4(1): 102062.
• 2023
  Domenger A, Ricci D, Mayau V, Majlessi L, Marcireau C, Dadaglio G, Demangel C, , Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma., Front Oncol 2023 ; 13(): 1110916.
• 2022
  Domenger A, Choisy C, Baron L, Mayau V, Perthame E, Deriano L, Arnulf B, Bories JC, Dadaglio G, Demangel C, , The Sec61 translocon is a therapeutic vulnerability in multiple myeloma., EMBO Mol Med 2022 03; 14(3): e14740.
• 2022
  Rifflet A, Demangel C, Guenin-Macé L, , Mycolactone Purification from M. ulcerans Cultures and HPLC-Based Approaches for Mycolactone Quantification in Biological Samples., Methods Mol Biol 2022 ; 2387(): 117-130.
• 2022
  O'Keefe S, High S, Demangel C, , Biochemical and Biological Assays of Mycolactone-Mediated Inhibition of Sec61., Methods Mol Biol 2022 ; 2387(): 163-181.
• 2021
  Laval T, Pedró-Cos L, Malaga W, Guenin-Macé L, Pawlik A, Mayau V, Yahia-Cherbal H, Delos O, Frigui W, Bertrand-Michel J, Guilhot C, Demangel C, , De novo synthesized polyunsaturated fatty acids operate as both host immunomodulators and nutrients for Mycobacterium tuberculosis., Elife 2021 Dec; 10(): .
• 2021
  Guan Q, Garbati M, Mfarrej S, AlMutairi T, Laval T, Singh A, Fagbo S, Smyth A, Browne JA, urRahman MA, Alruwaili A, Hoosen A, Meehan CJ, Nakajima C, Suzuki Y, Demangel C, Bhatt A, Gordon SV, AlAsmari F, Pain A, , Insights into the ancestry evolution of the Mycobacterium tuberculosis complex from analysis of Mycobacterium riyadhense., NAR Genom Bioinform 2021 Sep; 3(3): lqab070.
• 2021
  Demangel C, , Immunity against Mycobacterium ulcerans: The subversive role of mycolactone., Immunol Rev 2021 Feb; (): .
• 2021
  Laval T, Chaumont L, Demangel C, , Not too fat to fight: The emerging role of macrophage fatty acid metabolism in immunity to Mycobacterium tuberculosis., Immunol Rev 2021 Feb; (): .
• 2021
  Tello Rubio B, Bugault F, Baudon B, Raynal B, Brûlé S, Morel JD, Saint-Auret S, Blanchard N, Demangel C, Guenin-Macé L, , Molecular Mechanisms Underpinning the Circulation and Cellular Uptake of Mycobacterium ulcerans Toxin Mycolactone., Front Pharmacol 2021 ; 12(): 733496.
• 2021
  Llibre A, Dedicoat M, Burel JG, Demangel C, O'Shea MK, Mauro C, , Host Immune-Metabolic Adaptations Upon Mycobacterial Infections and Associated Co-Morbidities., Front Immunol 2021 ; 12(): 747387.
• 2020
  Chevalier G, Siopi E, Guenin-Macé L, Pascal M, Laval T, Rifflet A, Boneca IG, Demangel C, Colsch B, Pruvost A, Chu-Van E, Messager A, Leulier F, Lepousez G, Eberl G, Lledo PM, , Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system., Nat Commun 2020 12; 11(1): 6363.
• 2020
  Colucci-Guyon E, Rifflet A, Saint-Auret S, da Costa A, Boucontet L, Laval T, Prehaud C, Blanchard N, Levraud JP, Boneca IG, Demangel C, Guenin-Macé L, , Spatiotemporal analysis of mycolactone distribution in vivo reveals partial diffusion in the central nervous system., PLoS Negl Trop Dis 2020 Dec; 14(12): e0008878.
• 2020
  Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, Dorgham K, Philippot Q, Rosain J, Béziat V, Manry J, Shaw E, Haljasmägi L, Peterson P, Lorenzo L, Bizien L, Trouillet-Assant S, Dobbs K, de Jesus AA, Belot A, Kallaste A, Catherinot E, Tandjaoui-Lambiotte Y, Le Pen J, Kerner G, Bigio B, Seeleuthner Y, Yang R, Bolze A, Spaan AN, Delmonte OM, Abers MS, Aiuti A, Casari G, Lampasona V, Piemonti L, Ciceri F, Bilguvar K, Lifton RP, Vasse M, Smadja DM, Migaud M, Hadjadj J, Terrier B, Duffy D, Quintana-Murci L, van de Beek D, Roussel L, Vinh DC, Tangye SG, Haerynck F, Dalmau D, Martinez-Picado J, Brodin P, Nussenzweig MC, Boisson-Dupuis S, Rodríguez-Gallego C, Vogt G, Mogensen TH, Oler AJ, Gu J, Burbelo PD, Cohen JI, Biondi A, Bettini LR, D'Angio M, Bonfanti P, Rossignol P, Mayaux J, Rieux-Laucat F, Husebye ES, Fusco F, Ursini MV, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Castagnoli R, Montagna D, Licari A, Marseglia GL, Duval X, Ghosn J, , , , , , , , , , , Tsang JS, Goldbach-Mansky R, Kisand K, Lionakis MS, Puel A, Zhang SY, Holland SM, Gorochov G, Jouanguy E, Rice CM, Cobat A, Notarangelo LD, Abel L, Su HC, Casanova JL, , Autoantibodies against type I IFNs in patients with life-threatening COVID-19., Science 2020 Oct; 370(6515): .
• 2020
  Yu W, Lescale C, Babin L, Bedora-Faure M, Lenden-Hasse H, Baron L, Demangel C, Yelamos J, Brunet E, Deriano L, , Repair of G1 induced DNA double-strand breaks in S-G2/M by alternative NHEJ., Nat Commun 2020 Oct; 11(1): 5239.
• 2020
  Förster B, Demangel C, Thye T, , Mycolactone induces cell death by SETD1B-dependent degradation of glutathione., 2020 Oct; 14(10): e0008709.
• 2020
  Guenin-Macé L, Morel JD, Doisne JM, Schiavo A, Boulet L, Mayau V, Goncalves P, Duchatelet S, Hovnanian A, Bondet V, Duffy D, Ungeheuer MN, Delage M, Nassif A, Di Santo JP, Demangel C, , Dysregulation of tryptophan catabolism at the host-skin microbiota interface in Hidradenitis Suppurativa., 2020 Sep 24;140598..
• 2019
  Doz-Deblauwe É, Carreras F, Arbues A, Remot A, Epardaud M, Malaga W, Mayau V, Prandi J, Astarie-Dequeker C, Guilhot C, Demangel C, Winter N, CR3 Engaged by PGL-I Triggers Syk-Calcineurin-NFATc to Rewire the Innate Immune Response in Leprosy, Front Immunol 2019;10:2913.
• 2019
  Scepanovic P, Hodel F, Mondot S, Partula V, Byrd A, Hammer C, Alanio C, Bergstedt J, Patin E, Touvier M, Lantz O, Albert ML, Duffy D, Quintana-Murci L, Fellay J, , , A comprehensive assessment of demographic, environmental, and host genetic associations with gut microbiome diversity in healthy individuals., Microbiome 2019 09; 7(1): 130.
• 2019
  Naranjo L, Ferrara F, Blanchard N, Demangel C, D'Angelo S, Erasmus MF, Teixera AA, Bradbury ARM, Recombinant Antibodies against Mycolactone, Toxins (Basel) 2019 Jun;11(6).
• 2019
  Zong G, Hu Z, O'Keefe S, Tranter D, Iannotti MJ, Baron L, Hall B, Corfield K, Paatero A, Henderson M, Roboti P, Zhou J, Sun X, Govindarajan M, Rohde J, Blanchard N, Simmonds R, Inglese J, Du Y, Demangel C, High S, Paavilainen VO, Shi WQ, Ipomoeassin F Binds Sec61α to Inhibit Protein Translocation, J. Am. Chem. Soc. 2019 May;.
• 2018
  Demangel C, High S, Sec61 blockade by mycolactone: A central mechanism in Buruli ulcer disease, Biol. Cell 2018 Jul;.
• 2018
  Scepanovic P, Alanio C, Hammer C, Hodel F, Bergstedt J, Patin E, Thorball CW, Chaturvedi N, Charbit B, Abel L, Quintana-Murci L, Duffy D, Albert ML, Fellay J, , , Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines., Genome Med 2018 Jul; 10(1): 59.
• 2018
  Morel JD, Paatero AO, Wei J, Yewdell JW, Guenin-Macé L, Van Haver D, Impens F, Pietrosemoli N, Paavilainen VO, Demangel C, Proteomics reveals scope of mycolactone-mediated Sec61 blockade and distinctive stress signature, Mol. Cell Proteomics 2018 Jun;.
• 2017
  Isaac C, Mauborgne A, Grimaldi A, Ade K, Pohl M, Limatola C, Boucher Y, Demangel C, Guenin-Macé L, Mycolactone displays anti-inflammatory effects on the nervous system, PLoS Negl Trop Dis 2017 Nov;11(11):e0006058.
• 2017
  Saint-Auret S, Abdelkafi H, Le Nouen D, Guenin-Macé L, Demangel C, Bisseret P, Blanchard N, Modular total syntheses of mycolactone A/B and its [(2)H]-isotopologue, Org. Biomol. Chem. 2017 Sep;15(36):7518-7522.
• 2017
  Grotzke JE, Kozik P, Morel JD, Impens F, Pietrosemoli N, Cresswell P, Amigorena S, Demangel C, Sec61 blockade by mycolactone inhibits antigen cross-presentation independently of endosome-to-cytosol export, Proc. Natl. Acad. Sci. U.S.A. 2017 Jul;114(29):E5910-E5919.
• 2017
  Monel B, Compton AA, Bruel T, Amraoui S, Burlaud-Gaillard J, Roy N, Guivel-Benhassine F, Porrot F, Génin P, Meertens L, Sinigaglia L, Jouvenet N, Weil R, Casartelli N, Demangel C, Simon-Lorière E, Moris A, Roingeard P, Amara A, Schwartz O, , Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells., EMBO J. 2017 06; 36(12): 1653-1668.
• 2017
  Oldenburg R, Demangel C, Pathogenic and immunosuppressive properties of mycobacterial phenolic glycolipids, Biochimie 2017 Mar;.
• 2016
  Baron L, Paatero AO, Morel JD, Impens F, Guenin-Macé L, Saint-Auret S, Blanchard N, Dillmann R, Niang F, Pellegrini S, Taunton J, Paavilainen VO, Demangel C, , Mycolactone subverts immunity by selectively blocking the Sec61 translocon., J Exp Med 2016 12; 213(13): 2885-2896.
• 2016
  Urrutia A, Duffy D, Rouilly V, Posseme C, Djebali R, Illanes G, Libri V, Albaud B, Gentien D, Piasecka B, Hasan M, Fontes M, Quintana-Murci L, Albert ML, , , Standardized Whole-Blood Transcriptional Profiling Enables the Deconvolution of Complex Induced Immune Responses., Cell Rep 2016 Sep; 16(10): 2777-2791.
• 2015
  Niang F, Sarfo FS, Frimpong M, Guenin-Macé L, Wansbrough-Jones M, Stinear T, Phillips RO, Demangel C, , Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease., Sci Rep 2015 Dec; 5(): 17693.
• 2015
  Guenin-Macé L, Baron L, Chany AC, Tresse C, Saint-Auret S, Jönsson F, Le Chevalier F, Bruhns P, Bismuth G, Hidalgo-Lucas S, Bisson JF, Blanchard N, Demangel C, , Shaping mycolactone for therapeutic use against inflammatory disorders., Sci Transl Med 2015 May; 7(289): 289ra85.
• 2014
  Chany AC, Veyron-Churlet R, Tresse C, Mayau V, Casarotto V, Le Chevalier F, Guenin-Macé L, Demangel C, Blanchard N, Synthetic variants of mycolactone bind and activate Wiskott-Aldrich syndrome proteins, J. Med. Chem. 2014 Sep;57(17):7382-95.
• 2014
  Geroult S, Phillips RO, Demangel C, Adhesion of the ulcerative pathogen Mycobacterium ulcerans to DACC-coated dressings, J Wound Care 2014 Aug;23(8):417-8, 422-4.
• 2014
  Phillips RO, Sarfo FS, Landier J, Oldenburg R, Frimpong M, Wansbrough-Jones M, Abass K, Thompson W, Forson M, Fontanet A, Niang F, Demangel C, , Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer disease., PLoS Negl Trop Dis 2014 Apr; 8(4): e2786.
• 2014
  Guenin-Macé L, Oldenburg R, Chrétien F, Demangel C, Pathogenesis of skin ulcers: lessons from the Mycobacterium ulcerans and Leishmania spp. pathogens, Cell. Mol. Life Sci. 2014 Jul;71(13):2443-50.
• 2013
  Bounab Y, Hesse AM, Iannascoli B, Grieco L, Couté Y, Niarakis A, Roncagalli R, Lie E, Lam KP, Demangel C, Thieffry D, Garin J, Malissen B, Daëron M, Proteomic analysis of the SH2 domain-containing leukocyte protein of 76 kDa (SLP76) interactome in resting and activated primary mast cells [corrected], Mol. Cell Proteomics 2013 Oct;12(10):2874-89.
• 2013
  Guenin-Macé L, Veyron-Churlet R, Thoulouze MI, Romet-Lemonne G, Hong H, Leadlay PF, Danckaert A, Ruf MT, Mostowy S, Zurzolo C, Bousso P, Chrétien F, Carlier MF, Demangel C, Mycolactone activation of Wiskott-Aldrich syndrome proteins underpins Buruli ulcer formation, J. Clin. Invest. 2013 Apr;123(4):1501-12.
• 2012
  Biot C, Rentsch CA, Gsponer JR, Birkhäuser FD, Jusforgues-Saklani H, Lemaître F, Auriau C, Bachmann A, Bousso P, Demangel C, Peduto L, Thalmann GN, Albert ML, Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer, Sci Transl Med 2012 Jun;4(137):137ra72.
• 2012
  Houben D, Demangel C, van Ingen J, Perez J, Baldeón L, Abdallah AM, Caleechurn L, Bottai D, van Zon M, de Punder K, van der Laan T, Kant A, Bossers-de Vries R, Willemsen P, Bitter W, van Soolingen D, Brosch R, van der Wel N, Peters PJ, ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria, Cell. Microbiol. 2012 Aug;14(8):1287-98.
• 2011
  Chany AC, Casarotto V, Schmitt M, Tarnus C, Guenin-Macé L, Demangel C, Mirguet O, Eustache J, Blanchard N, A diverted total synthesis of mycolactone analogues: an insight into Buruli ulcer toxins, Chemistry 2011 Dec;17(51):14413-9.
• 2011
  Sarfo FS, Le Chevalier F, Aka N, Phillips RO, Amoako Y, Boneca IG, Lenormand P, Dosso M, Wansbrough-Jones M, Veyron-Churlet R, Guenin-Macé L, Demangel C, Mycolactone diffuses into the peripheral blood of Buruli ulcer patients–implications for diagnosis and disease monitoring, PLoS Negl Trop Dis 2011 Jul;5(7):e1237.
• 2011
  Guenin-Macé L, Carrette F, Asperti-Boursin F, Le Bon A, Caleechurn L, Di Bartolo V, Fontanet A, Bismuth G, Demangel C, , Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression., Proc. Natl. Acad. Sci. U.S.A. 2011 Aug; 108(31): 12833-8.
• 2010
  Tabouret G, Astarie-Dequeker C, Demangel C, Malaga W, Constant P, Ray A, Honoré N, Bello NF, Perez E, Daffé M, Guilhot C, Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes, PLoS Pathog. 2010;6(10):e1001159.
• 2009
  Phillips R, Sarfo FS, Guenin-Macé L, Decalf J, Wansbrough-Jones M, Albert ML, Demangel C, Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease, J. Infect. Dis. 2009 Dec;200(11):1675-84.
• 2009
  Guenin-Macé L, Siméone R, Demangel C, Lipids of pathogenic Mycobacteria: contributions to virulence and host immune suppression, Transbound Emerg Dis 2009 Aug;56(6-7):255-68.
• 2009
  Huygen K, Adjei O, Affolabi D, Bretzel G, Demangel C, Fleischer B, Johnson RC, Pedrosa J, Phanzu DM, Phillips RO, Pluschke G, Siegmund V, Singh M, van der Werf TS, Wansbrough-Jones M, Portaels F, Buruli ulcer disease: prospects for a vaccine, Med. Microbiol. Immunol. 2009 May;198(2):69-77.
• 2009
  Demangel C, Stinear TP, Cole ST, Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans, Nat. Rev. Microbiol. 2009 Jan;7(1):50-60.
• 2008
  Hong H, Coutanceau E, Leclerc M, Caleechurn L, Leadlay PF, Demangel C, Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs, PLoS Negl Trop Dis 2008;2(10):e325.
• 2008
  Hong H, Demangel C, Pidot SJ, Leadlay PF, Stinear T, Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria, Nat Prod Rep 2008 Jun;25(3):447-54.
• 2007
  Hong H, Stinear T, Porter J, Demangel C, Leadlay PF, A novel mycolactone toxin obtained by biosynthetic engineering, Chembiochem 2007 Nov;8(17):2043-7.
• 2007
  Coutanceau E, Decalf J, Martino A, Babon A, Winter N, Cole ST, Albert ML, Demangel C, Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone, J. Exp. Med. 2007 Jun;204(6):1395-403.
• 2006
  Saint-Joanis B, Demangel C, Jackson M, Brodin P, Marsollier L, Boshoff H, Cole ST, Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence, J. Bacteriol. 2006 Sep;188(18):6669-79.
• 2006
  Aráoz R, Honoré N, Banu S, Demangel C, Cissoko Y, Arama C, Uddin MK, Hadi SK, Monot M, Cho SN, Ji B, Brennan PJ, Sow S, Cole ST, Towards an immunodiagnostic test for leprosy, Microbes Infect. 2006 Jul;8(8):2270-6.
• 2006
  Coutanceau E, Legras P, Marsollier L, Reysset G, Cole ST, Demangel C, Immunogenicity of Mycobacterium ulcerans Hsp65 and protective efficacy of a Mycobacterium leprae Hsp65-based DNA vaccine against Buruli ulcer, Microbes Infect. 2006 Jul;8(8):2075-81.
• 2006
  Brodin P, Majlessi L, Marsollier L, de Jonge MI, Bottai D, Demangel C, Hinds J, Neyrolles O, Butcher PD, Leclerc C, Cole ST, Brosch R, Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence, Infect. Immun. 2006 Jan;74(1):88-98.
• 2006
  Aráoz R, Honoré N, Cho S, Kim JP, Cho SN, Monot M, Demangel C, Brennan PJ, Cole ST, Antigen discovery: a postgenomic approach to leprosy diagnosis, Infect. Immun. 2006 Jan;74(1):175-82.
• 2005
  de Jonge MI, Brosch R, Brodin P, Demangel C, Cole ST, Tuberculosis: from genome to vaccine, Expert Rev Vaccines 2005 Aug;4(4):541-51.
• 2005
  Coutanceau E, Marsollier L, Brosch R, Perret E, Goossens P, Tanguy M, Cole ST, Small PL, Demangel C, Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin, Cell. Microbiol. 2005 Aug;7(8):1187-96.
• 2005
  Demangel C, Garnier T, Rosenkrands I, Cole ST, Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens, Infect. Immun. 2005 Apr;73(4):2190-6.
• 2004
  Demangel C, Zhou J, Choo AB, Shoebridge G, Halliday GM, Britton WJ, Single chain antibody fragments for the selective targeting of antigens to dendritic cells, Mol. Immunol. 2005 May;42(8):979-85.
• 2004
  van Broekhoven CL, Parish CR, Demangel C, Britton WJ, Altin JG, , Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy., Cancer Res 2004 Jun; 64(12): 4357-65.
• 2004
  Demangel C, Brodin P, Cockle PJ, Brosch R, Majlessi L, Leclerc C, Cole ST, Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6, Infect. Immun. 2004 Apr;72(4):2170-6.
• 2003
  Pym AS, Brodin P, Majlessi L, Brosch R, Demangel C, Williams A, Griffiths KE, Marchal G, Leclerc C, Cole ST, Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis, Nat. Med. 2003 May;9(5):533-9.
• 2002
  Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ, TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection, J. Immunol. 2002 May;168(9):4620-7.
• 2002
  Demangel C, Bertolino P, Britton WJ, Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production, Eur. J. Immunol. 2002 Apr;32(4):994-1002.
• 2001
  Thullier P, Demangel C, Bedouelle H, Mégret F, Jouan A, Deubel V, Mazié JC, Lafaye P, Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism, J. Gen. Virol. 2001 Aug;82(Pt 8):1885-92.
• 2001
  Feng CG, Palendira U, Demangel C, Spratt JM, Malin AS, Britton WJ, Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis, Infect. Immun. 2001 Jun;69(6):4174-6.
• 2001
  Feng CG, Demangel C, Kamath AT, Macdonald M, Britton WJ, Dendritic cells infected with Mycobacterium bovis bacillus Calmette Guerin activate CD8(+) T cells with specificity for a novel mycobacterial epitope, Int. Immunol. 2001 Apr;13(4):451-8.
• 2001
  Demangel C, Palendira U, Feng CG, Heath AW, Bean AG, Britton WJ, Stimulation of dendritic cells via CD40 enhances immune responses to Mycobacterium tuberculosis infection, Infect. Immun. 2001 Apr;69(4):2456-61.
• 2000
  Demangel C, Britton WJ, Interaction of dendritic cells with mycobacteria: where the action starts, Immunol. Cell Biol. 2000 Aug;78(4):318-24.
• 2000
  Binétruy-Tournaire R, Demangel C, Malavaud B, Vassy R, Rouyre S, Kraemer M, Plouët J, Derbin C, Perret G, Mazié JC, Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, EMBO J. 2000 Apr;19(7):1525-33.
• 2000
  Demangel C, Maroun RC, Rouyre S, Bon C, Mazié JC, Choumet V, Combining phage display and molecular modeling to map the epitope of a neutralizing antitoxin antibody, Eur. J. Biochem. 2000 Apr;267(8):2345-53.
• 1999
  Demangel C, Bean AG, Martin E, Feng CG, Kamath AT, Britton WJ, Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells, Eur. J. Immunol. 1999 Jun;29(6):1972-9.
• 1999
  Choumet V, Lafaye P, Demangel C, Bon C, Mazié JC, Molecular mimicry between a monoclonal antibody and one subunit of crotoxin, a heterodimeric phospholipase A2 neurotoxin, Biol. Chem. 1999 May;380(5):561-8.
• 1998
  Demangel C, Rouyre S, Alzari PM, Nato F, Longacre S, Lafaye P, Mazie JC, Phage-displayed mimotopes elicit monoclonal antibodies specific for a malaria vaccine candidate, Biol. Chem. 1998 Jan;379(1):65-70.
• 1997
  Muller BH, Lafay F, Demangel C, Perrin P, Tordo N, Flamand A, Lafaye P, Guesdon JL, Phage-displayed and soluble mouse scFv fragments neutralize rabies virus, J. Virol. Methods 1997 Sep;67(2):221-33.
• 1997
  Lafaye P, Choumet V, Demangel C, Bon C, Mazié JC, Biologically active human anti-crotoxin scFv isolated from a semi-synthetic phage library, Immunotechnology 1997 Jun;3(2):117-25.
• 1996
  Demangel C, Lafaye P, Mazie JC, Reproducing the immune response against the Plasmodium vivax merozoite surface protein 1 with mimotopes selected from a phage-displayed peptide library, Mol. Immunol. 1996 Aug;33(11-12):909-16.
• 1993
  Maillard JC, Kemp SJ, Naves M, Palin C, Demangel C, Accipe A, Maillard N, Bensaid A, An attempt to correlate cattle breed origins and diseases associated with or transmitted by the tick Amblyomma variegatum in the French West Indies, Rev Elev Med Vet Pays Trop 1993;46(1-2):283-90.
• 1992
  Legrand C, Bour JM, Jacob C, Capiaumont J, Martial A, Marc A, Wudtke M, Kretzmer G, Demangel C, Duval D, Lactate dehydrogenase (LDH) activity of the cultured eukaryotic cells as marker of the number of dead cells in the medium [corrected], J. Biotechnol. 1992 Sep;25(3):231-43.
• 1992
  Duval D, Demangel C, Miossec S, Geahel I, Role of metabolic waste products in the control of cell proliferation and antibody production by mouse hybridoma cells, Hybridoma 1992 Jun;11(3):311-22.
• 1991
  Duval D, Demangel C, Munier-Jolain K, Miossec S, Geahel I, Factors controlling cell proliferation and antibody production in mouse hybridoma cells: I. Influence of the amino acid supply, Biotechnol. Bioeng. 1991 Sep;38(6):561-70.
• 1990
  Duval D, Demangel C, Geahel I, Blondeau K, Marcadet A, Comparison of various methods for monitoring hybridoma cell proliferation, J. Immunol. Methods 1990 Dec;134(2):177-85.